An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington School of Medicine in Seattle report in a paper published by the ...
Nov 3, 2022
0
2102
Children aged 8 years or younger should be considered a group at high risk for more severe monkeypox disease, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric ...
Oct 28, 2022
0
11
The Chinese city of Shanghai started administering an inhalable COVID-19 vaccine on Wednesday in what appears to be a world first.
Oct 26, 2022
0
46
A clinical trial evaluating two different immunization schedules for a new COVID-19 vaccine shows that both regimens generate a similar immune response, according to results published today in eLife.
Oct 25, 2022
0
16
Maybe you've never heard of the Epstein-Barr virus. But it knows all about you.
Oct 20, 2022
0
31
New trial data shows that Pfizer's updated COVID booster shot is more powerful against Omicron subvariants than the original shot, the company announced Thursday.
Oct 14, 2022
0
11
The European Medicines Agency on Friday recommended the authorization of a dengue vaccine made by the Japanese pharmaceutical Takeda that could provide a new tool for millions worldwide against the potentially fatal disease.
Oct 14, 2022
0
21
The original COVID-19 boosters did a great job of preventing severe illness and hospitalization, even during the delta surge. Then came omicron and its subvariants, which are more transmissible than previous variants and ...
Oct 7, 2022
0
4
Testing on humans of a novel COVID-19 vaccine developed in Brazil will begin this year. It performed well in animal trials, as reported in an article published in August in Nature Communications. The scientists responsible ...
Oct 6, 2022
0
10
The U.K. conducted world-leading COVID-19 research and was the first country to find a treatment that worked, so why did it also have such a high death rate?
Sep 27, 2022
0
14
